Log In
Print this Print this


Also known as: Anti-CD70 antibody-drug conjugate

  Manage Alerts
Collapse Summary General Information
Company Bristol-Myers Squibb Co.
DescriptionAntibody to CD70
Molecular Target CD70 (CD27L)
Mechanism of ActionAntibody-drug conjugate
Therapeutic ModalityBiologic: Antibody-drug conjugate
Latest Stage of DevelopmentPhase II
Standard IndicationRenal cancer
Indication DetailsTreat clear cell renal cell carcinoma (RCC)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today